Kappas A, Bradlow H L, Gillette P N, Gallagher T F
J Exp Med. 1972 Nov 1;136(5):1043-53. doi: 10.1084/jem.136.5.1043.
A variety of 5beta steroid metabolites derived from hormones natural to man are potent inducers experimentally of delta-aminolevulinate synthetase, the rate-limiting enzyme in porphyrin-heme formation. This mitochondrial enzyme is found at high levels of activity in the livers of patients with the genetic disease, acute intermittent porphyria (AIP). In this study the metabolism of (14)C-labeled testosterone was examined in AIP patients to determine whether there was a disproportionate conversion of the hormone to its 5beta, compared to its 5alpha metabolite. The results indicate that AIP subjects do generate a substantially greater than normal fraction of 5beta metabolite from this steroid; the excessive degree of ring A reduction of testosterone taking place via the 5beta pathway in the porphyric patients averages 350% greater than in the nonporphyric subjects. In one asymptomatic AIP patient the disproportionate generation of 5beta metabolite from the hormone reached a level 10 times the normal mean. Studies with a second (14)C-labeled hormone, dehydroisoandrosterone, whose metabolism in man resembles that of testosterone, confirmed the derangement in reductive transformation of steroids found in the individuals carrying the genetic lesion of AIP. These findings define a new endocrine abnormality in AIP patients and raise the possibility that endogenously derived 5beta steroids may contribute by an induction mechanism to the increased levels of hepatic delta-aminolevulinate synthetase activity found in AIP patients.
多种源自人体天然激素的5β类固醇代谢产物在实验中是δ-氨基乙酰丙酸合成酶的有效诱导剂,该酶是卟啉-血红素形成过程中的限速酶。在患有遗传性疾病急性间歇性卟啉病(AIP)的患者肝脏中,这种线粒体酶的活性水平很高。在本研究中,对AIP患者体内(14)C标记的睾酮代谢进行了检测,以确定与5α代谢产物相比,该激素向其5β代谢产物的转化是否存在不成比例的情况。结果表明,AIP患者确实从这种类固醇产生了比正常比例大得多的5β代谢产物;卟啉病患者中通过5β途径发生的睾酮A环过度还原程度平均比非卟啉病患者高350%。在一名无症状的AIP患者中,该激素产生的5β代谢产物不成比例的情况达到了正常平均值的10倍。对第二种(14)C标记的激素脱氢异雄酮的研究证实了携带AIP遗传病变个体中类固醇还原转化的紊乱,该激素在人体内的代谢与睾酮相似。这些发现定义了AIP患者一种新的内分泌异常情况,并增加了内源性5β类固醇可能通过诱导机制导致AIP患者肝脏中δ-氨基乙酰丙酸合成酶活性升高的可能性。